Thirdeye Systems Ltd. Logo

Thirdeye Systems Ltd.

Develops AI object recognition algorithms and hardware for the thermal spectrum.

THES | TA

Overview

Corporate Details

ISIN(s):
IL0003970188
LEI:
Country:
Israel
Address:
8 Ha-Melakha St., 4250543 Netanya

Description

Thirdeye Systems Ltd. is a research and development company specializing in high-end, AI-powered object recognition algorithms, with a primary focus on the thermal spectrum. The company develops solutions that leverage deep neural networks and fuse thermal with visible light imaging to enable advanced perception. Its product portfolio includes both software analytics that can be integrated into third-party electro-optical/infrared (EO/IR) systems and complete hardware payloads. These systems are designed for applications such as counter-drone (C-UAV) security, perception for unmanned ground vehicles (UGV), and aerial surveillance. The technology provides real-time, automatic detection, classification, and tracking of objects like drones, vehicles, and humans in various operational conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-09-13 16:38
Opening of Trading On September 14 2022- THIRDEYE W2, THIRDEYE W3
Hebrew (modern) 176.1 KB
2022-09-12 16:03
Identifying Details of New Securities-THIRDEYE W2, THIRDEYE W3
Hebrew (modern) 89.2 KB
2022-05-01 11:29
Company's Presentation-May 2022
Hebrew (modern) 1.7 MB
2022-05-01 11:29
Company's Presentation-May 2022
Russian 42.6 KB
2021-06-03 14:17
Discontinuation of Market Making
Hebrew (modern) 186.2 KB
2021-05-20 20:31
On June 3th, 2021, following seasoned shares will be added to the respective in…
Hebrew (modern) 333.6 KB
2021-05-13 15:52
Changes in company's and securities names effective of May 18, 2021
Hebrew (modern) 149.3 KB
2021-04-12 10:25
change the sector classification of the company from - - REAL-ESTATE & CONSTRUC…
Hebrew (modern) 148.1 KB
2021-02-01 18:38
On February 2, 2021, the company's securities will be transferred from the main…
Hebrew (modern) 150.0 KB

Automate Your Workflow. Get a real-time feed of all Thirdeye Systems Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Thirdeye Systems Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Thirdeye Systems Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Genenta Science S.p.A. Logo
Clinical-stage developer of hematopoietic stem cell gene therapies for immuno-oncology.
United States of America
GNTA
GeneOne Life Science, Inc. Logo
Biopharmaceutical R&D company specializing in nucleic acid-based biomedicines.
South Korea
011000
Geneuro Logo
Develops therapies for neurological and autoimmune diseases by targeting HERVs.
Switzerland
GEM
GENFIT Logo
Develops therapies and diagnostics for patients with rare and severe liver diseases.
France
GNFT
GENFLOW BIOSCIENCES PLC Logo
A biotechnology company developing gene therapies that target the aging process.
United Kingdom
GENF
GENINCODE PLC Logo
Specializes in genetic risk assessment and prediction of cardiovascular disease.
United Kingdom
GENI
GENINUS Inc. Logo
A biotech company offering genomic analysis for precision medicine and drug development.
South Korea
389030
Genomed Spolka Akcyjna Logo
Biotechnology firm for genetic research and molecular diagnostics using NGS technology.
Poland
GEN
A molecular diagnostics company developing tests for the early detection of cancer.
South Korea
228760
Genomic Vision Logo
Provides DNA analysis and quality control for bioproduction and gene therapy.
France
GV

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.